Safayet Jamil, Masoud Mohammadnezhad, Abdulrakib Abdulrahim, Faisal Muhammad, Hafiz T. A. Khan
{"title":"Managing Diabetes One Step at a Time in Low- and Middle-Income Countries: The Promise of Wearable Devices","authors":"Safayet Jamil, Masoud Mohammadnezhad, Abdulrakib Abdulrahim, Faisal Muhammad, Hafiz T. A. Khan","doi":"10.1002/cdt3.70018","DOIUrl":null,"url":null,"abstract":"<p>The global burden of diabetes mellitus disproportionately affects low- and middle-income countries (LMICs), where limited healthcare infrastructure hampers timely and effective disease management. Wearable technologies, such as continuous glucose monitors (CGMs), insulin pumps, and fitness trackers, offer a transformative opportunity to bridge care gaps by enabling real-time monitoring, personalized feedback, and improved glycemic control. Evidence shows how wearables enhance patient engagement, support clinical decision-making, and reduce complications. However, significant barriers such as cost, digital illiteracy, poor system integration, and data privacy concerns impede widespread adoption in LMICs. Case studies from Ghana, China, and Ethiopia illustrate these devices' potential and challenges in resource-limited settings. Policy interventions, such as public-private partnerships, subsidies, simplified interfaces, and digital literacy programs, are essential to overcome these obstacles. Furthermore, integrating wearable data into national health systems and leveraging artificial intelligence can improve individualized care and long-term outcomes. As mobile phone use increases in LMICs, coupling wearables with mHealth platforms could further empower self-management. With targeted investments and regulatory support, wearable technologies can be pivotal in advancing equitable, proactive, and data-driven diabetes care across underserved populations.</p>","PeriodicalId":32096,"journal":{"name":"Chronic Diseases and Translational Medicine","volume":"11 4","pages":"279-283"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cdt3.70018","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chronic Diseases and Translational Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cdt3.70018","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
The global burden of diabetes mellitus disproportionately affects low- and middle-income countries (LMICs), where limited healthcare infrastructure hampers timely and effective disease management. Wearable technologies, such as continuous glucose monitors (CGMs), insulin pumps, and fitness trackers, offer a transformative opportunity to bridge care gaps by enabling real-time monitoring, personalized feedback, and improved glycemic control. Evidence shows how wearables enhance patient engagement, support clinical decision-making, and reduce complications. However, significant barriers such as cost, digital illiteracy, poor system integration, and data privacy concerns impede widespread adoption in LMICs. Case studies from Ghana, China, and Ethiopia illustrate these devices' potential and challenges in resource-limited settings. Policy interventions, such as public-private partnerships, subsidies, simplified interfaces, and digital literacy programs, are essential to overcome these obstacles. Furthermore, integrating wearable data into national health systems and leveraging artificial intelligence can improve individualized care and long-term outcomes. As mobile phone use increases in LMICs, coupling wearables with mHealth platforms could further empower self-management. With targeted investments and regulatory support, wearable technologies can be pivotal in advancing equitable, proactive, and data-driven diabetes care across underserved populations.
期刊介绍:
This journal aims to promote progress from basic research to clinical practice and to provide a forum for communication among basic, translational, and clinical research practitioners and physicians from all relevant disciplines. Chronic diseases such as cardiovascular diseases, cancer, diabetes, stroke, chronic respiratory diseases (such as asthma and COPD), chronic kidney diseases, and related translational research. Topics of interest for Chronic Diseases and Translational Medicine include Research and commentary on models of chronic diseases with significant implications for disease diagnosis and treatment Investigative studies of human biology with an emphasis on disease Perspectives and reviews on research topics that discuss the implications of findings from the viewpoints of basic science and clinical practic.